Skip to main content
Top
Published in: Familial Cancer 3/2010

01-09-2010

A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma

Authors: Fatemeh Abbaszadeh, Karen T. Barker, Carmel McConville, Richard H. Scott, Nazneen Rahman

Published in: Familial Cancer | Issue 3/2010

Login to get access

Abstract

Wilms tumor and neuroblastoma are childhood tumors of the kidney and undifferentiated neural crest cells, respectively. Both disorders are primarily sporadic, but familial Wilms tumor pedigrees and familial neuroblastoma pedigrees are each well recognized and account for approximately 1–3% of each tumor type. Families with Wilms tumor and neuroblastoma in the same, or related individuals, have not been reported. Here, we present nine families with two or more individuals with Wilms tumor and/or neuroblastoma. The affected individuals were otherwise well, without syndromic features. Although this co-occurrence might be due to chance in some families, the coexistence of two rare embryonal tumors in related individuals of multiple families suggests an underlying genetic susceptibility to both tumors. We undertook mutational analysis of the genes known to predispose to non-syndromic familial Wilms tumor (WT1) or neuroblastoma (PHOX2B, ALK) which excluded these as the underlying predisposition genes in the nine families. We also excluded epigenetic and copy-number abnormalities at 11p15 which are known to predispose to embryonal tumors including Wilms tumor and neuroblastoma. Overall, these data suggest that families with both Wilms tumor and neuroblastoma represent a previously unrecognized familial cancer syndrome in which the underlying predisposition gene(s) remain to be determined.
Appendix
Available only for authorised users
Literature
2.
go back to reference Stiller CA, Parkin DM (1990) International variations in the incidence of childhood renal tumors. Br J Cancer 62:1026–1030PubMed Stiller CA, Parkin DM (1990) International variations in the incidence of childhood renal tumors. Br J Cancer 62:1026–1030PubMed
3.
go back to reference Bolande RP (1977) Childhood tumors and their relationships to birth defects. In: Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds) Genetics of human cancer. Raven, New York, pp 43–75 Bolande RP (1977) Childhood tumors and their relationships to birth defects. In: Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds) Genetics of human cancer. Raven, New York, pp 43–75
4.
go back to reference Breslow N, Beckwith JB, Ciol M et al (1988) Age distribution of Wilms’ tumor: report from the national Wilms’ tumor study. Cancer Res 48:1653–1657PubMed Breslow N, Beckwith JB, Ciol M et al (1988) Age distribution of Wilms’ tumor: report from the national Wilms’ tumor study. Cancer Res 48:1653–1657PubMed
5.
go back to reference Scott RH, Stiller CA, Walker L et al (2006) Syndromes and constitutional chromosomal abnormalities associated with Wilms tumor. J Med Genet 43:705–715CrossRefPubMed Scott RH, Stiller CA, Walker L et al (2006) Syndromes and constitutional chromosomal abnormalities associated with Wilms tumor. J Med Genet 43:705–715CrossRefPubMed
6.
go back to reference Little SE, Hanks SP, King-Underwood L et al (2004) Frequency and heritability of WT1 mutations in nonsyndromic Wilms’ tumor patients: a UK children’s cancer study group study. J Clin Oncol 22:4140–4146CrossRefPubMed Little SE, Hanks SP, King-Underwood L et al (2004) Frequency and heritability of WT1 mutations in nonsyndromic Wilms’ tumor patients: a UK children’s cancer study group study. J Clin Oncol 22:4140–4146CrossRefPubMed
7.
go back to reference Scott RH, Douglas J, Baskcomb L et al (2008) Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause non-syndromic Wilms tumor. Nat Genet 40:1329–1334CrossRefPubMed Scott RH, Douglas J, Baskcomb L et al (2008) Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause non-syndromic Wilms tumor. Nat Genet 40:1329–1334CrossRefPubMed
8.
go back to reference Rahman N, Arbour L, Tonin P et al (1996) Evidence for a familial Wilms’ tumor gene (FWT1) on chromosome 17q12-q21. Nat Genet 13:461–643CrossRefPubMed Rahman N, Arbour L, Tonin P et al (1996) Evidence for a familial Wilms’ tumor gene (FWT1) on chromosome 17q12-q21. Nat Genet 13:461–643CrossRefPubMed
9.
go back to reference McDonald JM, Douglass EC, Fisher R et al (1998) Linkage of familial Wilms’ tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 58:1387–1390PubMed McDonald JM, Douglass EC, Fisher R et al (1998) Linkage of familial Wilms’ tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 58:1387–1390PubMed
10.
go back to reference Shimada H, Ambros IM, Dehner LP et al (1999) The international neuroblastoma pathology classification (the Shimada system). Cancer 86:364–372CrossRefPubMed Shimada H, Ambros IM, Dehner LP et al (1999) The international neuroblastoma pathology classification (the Shimada system). Cancer 86:364–372CrossRefPubMed
12.
go back to reference Amiel J, Laudier B, Attié-Bitach T et al (2003) Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459–461CrossRefPubMed Amiel J, Laudier B, Attié-Bitach T et al (2003) Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459–461CrossRefPubMed
13.
go back to reference Tatton-Brown K, Douglas J, Coleman K et al (2005) Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 77:193–204CrossRefPubMed Tatton-Brown K, Douglas J, Coleman K et al (2005) Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet 77:193–204CrossRefPubMed
14.
go back to reference Cohen MM Jr (2005) Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 8:287–304CrossRefPubMed Cohen MM Jr (2005) Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 8:287–304CrossRefPubMed
15.
go back to reference McConville C, Reid S, Baskcomb L et al (2006) PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations. Am J Med Genet A 140:1297–1301PubMed McConville C, Reid S, Baskcomb L et al (2006) PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations. Am J Med Genet A 140:1297–1301PubMed
16.
go back to reference Mossé YP, Laudenslager M, Longo L et al (2008) Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930–935CrossRefPubMed Mossé YP, Laudenslager M, Longo L et al (2008) Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930–935CrossRefPubMed
17.
go back to reference DeBaun MR, Tucker MA (1998) Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann syndrome registry. J Pediatr 132:398–400CrossRefPubMed DeBaun MR, Tucker MA (1998) Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann syndrome registry. J Pediatr 132:398–400CrossRefPubMed
18.
go back to reference Hoyme HE, Seaver LH, Jones KL et al (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274–278CrossRefPubMed Hoyme HE, Seaver LH, Jones KL et al (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274–278CrossRefPubMed
19.
go back to reference Rahman N (2005) Mechanisms predisposing to childhood overgrowth and cancer. Curr Opin Genet Dev 15:227–233CrossRefPubMed Rahman N (2005) Mechanisms predisposing to childhood overgrowth and cancer. Curr Opin Genet Dev 15:227–233CrossRefPubMed
20.
go back to reference Reid S, Renwick A, Seal S et al (2005) Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumor. J Med Genet 42:147–151CrossRefPubMed Reid S, Renwick A, Seal S et al (2005) Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumor. J Med Genet 42:147–151CrossRefPubMed
21.
go back to reference Faivre L, Portnoï MF, Pals G et al (2005) Should chromosome breakage studies be performed in patients with VACTERL association? Am J Med Genet A 137:55–58PubMed Faivre L, Portnoï MF, Pals G et al (2005) Should chromosome breakage studies be performed in patients with VACTERL association? Am J Med Genet A 137:55–58PubMed
22.
go back to reference Reid S, Schindler D, Hanenberg H et al (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39:162–164CrossRefPubMed Reid S, Schindler D, Hanenberg H et al (2007) Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39:162–164CrossRefPubMed
23.
go back to reference Scott RH, Douglas J, Baskcomb L (2008) Methylation-specific MLPA (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation. J Med Genet 45:106–113CrossRefPubMed Scott RH, Douglas J, Baskcomb L (2008) Methylation-specific MLPA (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation. J Med Genet 45:106–113CrossRefPubMed
24.
go back to reference London WB, Castleberry RP, Matthay KK et al (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children’s oncology group. J Clin Oncol 23:6459–6465CrossRefPubMed London WB, Castleberry RP, Matthay KK et al (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children’s oncology group. J Clin Oncol 23:6459–6465CrossRefPubMed
25.
go back to reference Cohn SL, Pearson AD, London WB et al (2009) The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27:289–297CrossRefPubMed Cohn SL, Pearson AD, London WB et al (2009) The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27:289–297CrossRefPubMed
Metadata
Title
A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma
Authors
Fatemeh Abbaszadeh
Karen T. Barker
Carmel McConville
Richard H. Scott
Nazneen Rahman
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-009-9319-8

Other articles of this Issue 3/2010

Familial Cancer 3/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine